NewLimit
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs.
Last updated on
About NewLimit
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$40MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
South San FranciscoState
CaliforniaCountry
United StatesNewLimit
Find your buyer within NewLimit
Tech Stack (22)
